![Stuart Kupfer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stuart Kupfer
Hoofd Techniek/Wetenschap/O&O bij
CYTOKINETICS, INCORPORATED
Profiel
Stuart Kupfer is Senior Vice President-Clinical Development at Cytokinetics, Inc. since 2026.
Formerly, Dr. Kupfer was Vice President & Head-Therapeutic Area at Takeda Pharmaceuticals U.S.A., Inc. from 2004 to 2016.
Dr. Kupfer also worked at the University of Washington.
Dr. Kupfer earned a doctorate from the University of Florida.
Actieve functies van Stuart Kupfer
| Bedrijven | Functie | Begin |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Hoofd Techniek/Wetenschap/O&O | 01-01-2020 |
Eerdere bekende functies van Stuart Kupfer
| Bedrijven | Functie | Einde |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01-01-2016 |
Opleiding van Stuart Kupfer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
67
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
